RXA

Pharmacy/Treatment Administration

Figure 4-21. RXA attributes usage
22
C.LenElementv2.3FHIR
1..4-NMR1-00342RXA-1Give Sub-ID CounterData Type-
2..4-NMR1-00344RXA-2Administration Sub-ID Counter-
3..26-TSR1-00345RXA-3Date/Time Start of AdministrationoccurrenceDateTime
4..26-TSR1-00346RXA-4Date/Time End of Administration-
5..100-CE_0292R1029200347RXA-5Administered CodeData TypevaccineCode
6..20-NMR1-00348RXA-6Administered AmountdoseQuantity.value
7..60-CEC1-00349RXA-7Administered UnitsdoseQuantity
8..60-CEO1-00350RXA-8Administered Dosage Form-
9..200-CEO*-00351RXA-9Administration NotesOptionality-
10..200-XCNO*-00352RXA-10Administering ProviderRepetition3 mappings
11..200-LA2C1-00353RXA-11Administered-at LocationData Type-
12..20-STC1-00354RXA-12Administered Per (Time Unit)-
13..20-NMO1-01134RXA-13Administered Strength-
14..60-CEO1-01135RXA-14Administered Strength Units-
15..20-STO*-01129RXA-15Substance Lot NumberlotNumber
16..26-TSO*-01130RXA-16Substance Expiration DateexpirationDate
17..60-CE_0227O*022701131RXA-17Substance Manufacturer NameData Typemanufacturer(Organization)
18..200-CEO*-01136RXA-18Substance Refusal ReasonLengthstatusReason
19..200-CEO*-01123RXA-19IndicationreasonCode
20..2-IDO1032201223RXA-20Completion Status2 mappings
21..2-IDO1032301224RXA-21Action Code-RXAstatus
22..26-TSO1-01225RXA-22System Entry Date/Timerecorded
6